CAMA-1 from ATCC

Product Specs
ItemCAMA-1
CompanyATCC
Price $551.00Supplier Page View Company Product Page
Catalog NumberHTB-21
TypeCell Biology
SpeciesHomo sapiens
TissueMammary gland, Breast
Cell LineCAMA-1
Validated Species ReactivityHuman (Hu)
Tissue (standardized)Breast
Age51 years
DiseaseAdenocarcinoma

Specifications/Features

Post freeze viability ≥ 50%

Add to Compare List

ATCC

10801 University Boulevard

Manassas, Virginia 20110-2209

United States

Phone: (703) 365-2700
Fax: (703) 365-2701

Company Profile

Website: http://www.atcc.org

(1) Advanced models of lobular breast cancer metastasis capture clinical organ tropism, endocrine response, and bone remodelingbioRxivMarch 18, 2026Joseph L. Sottnik, Mary E. Buchanan, Maria J Contreras-Zárate, Trinh C Pham, Maggie Musick, Thu H. Truong, Diana M Cittelly, Julie H. Ostrander, Matthew J. Sikoramaintained as previously described [28]. 293FT (Invitrogen) were maintained as directed. CAMA-1 (ATCC HTB-21), UACC-3133 (CRL-2988), and ZR-75–30 (CRL-1504) were maintained as described [29]. MC3T3-E1 (ATCC CRL-2593)

(2) The Interaction of CircESR1 and HNRNPAB Regulates Cell Cycle Transition of Breast Cancer CellInternational Journal of Biological SciencesJanuary 14, 2026Junchao Xu, Qiao Xu, Tingfang Cao, Miaomiao Wang, Yinzhong Shang, Junyan Tang, Sheng Wu, Xiaopeng Ma, Xinghua Han, Peter E. Lobie, et al.CRL-10317), HMEC-hTERT (ATCC PCS-600-010), MCF-7 (ATCC HTB-22), T-47D (ATCC HTB-133), CAMA-1 (ATCC HTB-21), BT-474 (ATCC HTB-20), ZR-75-1 (ATCC CRL-1500), MDA-MB-231 (ATCC HTB-26), MDA-MB-468 (ATCC HTB-132),

(3) Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancerElifeDecember 29, 2025Jessica Armand, Sungsoo Kim, Kibum Kim, Eugene Son, Minah Kim, Kevin Kalinsky, Hee Won Yangtherapeutic resistance. Materials and methods Cell culture MCF-7 (ATCC, HTB-22), CAMA-1 (ATCC, HTB-21), MDA-MB-231 (ATCC, CRM-HTB-26), and T47D (ATCC, HTB-133) cells were authenticated by ATCC using STR

(4) Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancereLifeDecember 29, 2025Jessica Armand, Sungsoo Kim, Kibum Kim, Eugene Son, Minah Kim, Kevin Kalinsky, Hee Won Yangtherapeutic resistance. Materials and methods Cell culture MCF-7 (ATCC, HTB-22), CAMA-1 (ATCC, HTB-21), MDA-MB-231 (ATCC, CRM-HTB-26), and T47D (ATCC, HTB-133) cells were authenticated by ATCC using STR

(5) Vesicle-mediated mitochondrial clearance presents an actionable metabolic vulnerability in triple-negative breast cancerCell Rep MedDecember 16, 2025Jody Vykoukal, Yihui Chen, Mingxin Zuo, Riccardo Ballarò, Monica J. Hong, Hansini Krishna, Daniela B. Rodriquez-Perera, Hiroyuki Katayama, Ehsan Irajizad, Ranran Wu, et al.Collection),HTB-20 BT-549,ATCC (American Type Culture Collection),HTB-122 CAMA-1,ATCC (American Type Culture Collection),HTB-21 DU4475,ATCC (American Type Culture Collection),HTB-123 HCC1143,ATCC (American Type Culture Collection),CRL-2321 HCC1187,ATCC

(6) System analysis links SMARCD3 regulons to growth signaling and MEK inhibitor response in everolimus-resistant ER+ breast cancer cellsCell Reports MedicineNovember 18, 2025Eric F. Medina, Elena Farmaki, Jason I. Griffiths, Andrea H. Bild, Aritro NathExperimental model and study participant details Development of everolimus-resistant ER+BC cell lines CAMA1 (ATCC HTB-21) and MCF7 (ATCC HTB-22) cell lines were maintained in Dulbeco’s Modified Eagle Medium (DMEM) supplemented

(7) Dual targeting of CDK4/6 and CDK7 augments tumor response and antitumor immunity in breast cancer modelsJournal of Clinical InvestigationOctober 15, 2025Sungsoo Kim, Eugene Son, Ha-Ram Park, Minah Kim, Hee Won Yangbreast cancer — primarily affects females. Cell lines. MCF-7 (HTB-22), MDA-MB-231 (CRM-HTB-26), and CAMA-1 (HTB-21) cell lines were obtained from ATCC and cultured in DMEM (Genesee Scientific; 25-500) supplemented with

(8) Dual targeting of CDK4/6 and CDK7 augments tumor response and antitumor immunity in breast cancer modelsJ Clin InvestAugust 12, 2025Sungsoo Kim, Eugene Son, Ha-Ram Park, Minah Kim, Hee Won Yangbreast cancer — primarily affects females. Cell lines. MCF-7 (HTB-22), MDA-MB-231 (CRM-HTB-26), and CAMA-1 (HTB-21) cell lines were obtained from ATCC and cultured in DMEM (Genesee Scientific; 25-500) supplemented with

(9) Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancerMolecular Systems BiologyMay 8, 2025Jason I Griffiths, Feng Chi, Elena Farmaki, Eric F Medina, Patrick A Cosgrove, Kimya L Karimi, Jinfeng Chen, Vince K Grolmusz, Frederick R Adler, Qamar J Khan, et al.number Experimental models,Experimental models,Experimental models 2003CAMA1 cells (H. sapiens),ATCC,HTB-21 MCF-7 cells (H. sapiens),ATCC,HTB-22 T47D cells (H. sapiens),ATCC,HTB-133 MRC5 cells (H. sapiens),ATCC,CCL-171 HEK-293 cells

(10) Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycleNature communicationsFebruary 9, 2025Kumarasamy V, Wang J, Roti M, Wan Y, Dommer AP, Rosenheck H, Putta S, Trub A, Bisi J, Strum J, et al.(IBC) at the Roswell Park Cancer Center. Cell culture and reagents MCF7 (ATCC, HTB-22), CAMA-1 (ATCC, HTB-21), MIA PaCa-2 (ATCC, CRM-CRL-1420) and MB157 (ATCC, HTB-24) cells are grown in DMEM medium supplemented

(11) Patient-derived response estimates from zero-passage organoids of luminal breast cancerBreast Cancer ResearchDecember 31, 2024Róża K. Przanowska, Najwa Labban, Piotr Przanowski, Russell B. Hawes, Kristen A. Atkins, Shayna L. Showalter, Kevin A. Janes#30-2001) supplemented with 10% FBS, 1% penicillin–streptomycin, and 0.2 Units/ml insulin. CAMA1 (ATCC, #HTB-21) were cultured in EMEM supplemented with 10% FBS and 1% penicillin–streptomycin. EFM19 (DSMZ, #ACC231)

(12) New Mitochondria-Targeted Fisetin Derivative Compromises Mitophagy and Limits Survival of Drug-Induced Senescent Breast Cancer CellsJournal of medicinal chemistryOctober 10, 2024Rzeszutek I, Cybularczyk-Cecotka M, Deręgowska A, Stec P, Wnuk M, Kołodziej O, Kałafut J, Wawruszak A, Witkowski W, Litwinienko G, et al.ER-positive breast cancer were used, namely, HCC1500 (CRL-2329, breast ductal carcinoma in situ), CAMA-1 (HTB-21, breast invasive lobular carcinoma), HCC1428 (CRL-2327, invasive breast carcinoma), and ZR-75-30 (CRL-1504,

(13) Proteome-wide copy-number estimation from transcriptomicsMolecular Systems BiologySeptember 27, 2024Andrew J Sweatt, Cameron D Griffiths, Sarah M Groves, B Bishal Paudel, Lixin Wang, David F Kashatus, Kevin A Janessapiens),"Wang et al, 2023",– BT20 (H. sapiens),ATCC,Cat # HTB-19 CAMA1 cells (H. sapiens),ATCC,Cat # HTB-21 "Coxsackievirus B3, Kandolf strain",Laboratory of Bruce McManus,Genbank # M33854 HCC1395 (H. sapiens),ATCC,Cat

(14) Progestogen-driven B7-H4 contributes to onco-fetal immune toleranceCellAugust 22, 2024Jiali Yu, Yijian Yan, Shasha Li, Ying Xu, Abhijit Parolia, Syed Rizvi, Weichao Wang, Yiwen Zhai, Rongxin Xiao, Xiong Li, et al.Lines HEK293T,ATCC,CRL-3126 JEG-3,ATCC,HTB-36 T-47D,ATCC,HTB-133 ZR-75-1,ATCC,CRL-1500 UACC-812,ATCC,CRL-1897 CAMA-1,ATCC,HTB-21 MDA-MB-231,ATCC,CRM-HTB-26 4T-1,ATCC,CRL-2539 OVKATE,AcceGen,ABC-TC0882 OVCAR-3,ATCC,HTB-161 LNCaP,ATCC,CRL-1740 3E10,This

(15) Uncovering the anti-breast cancer activity potential of east Kalimantan propolis by In vitro and bioinformatics analysisHeliyonJuly 15, 2024Paula Mariana Kustiawan, Khalish Arsy Al Khairy Siregar, Putri Hawa Syaifie, Fauzan Zein Muttaqin, Delfritama Ibadillah, Muhammad Miftah Jauhar, Nailulkamal Djamas, Etik Mardliyati, Nurul Taufiqu Rochmanhexane fraction (EEKP-HFr). 2.2 Cytotoxic determination by MTT assay The BT474 cell line, ATCC No. HTB 21, derived from ductal carcinoma, was used in this study. The cells were grown in RPMI 1640 medium supplemented

(16) Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcomaClin Cancer ResFebruary 16, 2024Caroline E. Gleason, Mark A. Dickson, Mary E. Klein (Dooley), Cristina R. Antonescu, Rodrigo Gularte-Mérida, Marimar Benitez, Juliana I. Delgado, Raghu P. Kataru, Mark Wei Yi Tan, Martina Bradic, et al.with 10% FBS and 2 mM glutamine. ZR-75-1 (ATCC Cat# CRL-1500, RRID:CVCL_0588) and CAMA-1 (ATCC Cat # HTB-21, RRID:CVCL_1290) were obtained from ATCC and cultured as pe their recommendations in RPMI-1640 supplemented

(17) Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated LiposarcomaClinical Cancer ResearchFebruary 16, 2024Caroline E. Gleason, Mark A. Dickson, Mary E. Klein (Dooley), Cristina R. Antonescu, Rodrigo Gularte-Mérida, Marimar Benitez, Juliana I. Delgado, Raghu P. Kataru, Mark Wei Yi Tan, Martina Bradic, et al.mmol/L glutamine. ZR-75–1 (ATCC, Catalog No. CRL-1500, RRID:CVCL_0588) and CAMA-1 (ATCC, Catalog No. HTB-21, RRID:CVCL_1290) were obtained from ATCC and cultured as pe their recommendations in RPMI1640 supplemented

(18) Tuning the potency and selectivity of ImmTAC molecules by affinity modulationClinical and Experimental ImmunologyFebruary 7, 2024Ian B Robertson, Rachel Mulvaney, Nele Dieckmann, Alessio Vantellini, Martina Canestraro, Francesca Amicarella, Ronan O’Dwyer, David K Cole, Stephen Harper, Omer Dushek, et al.lines used in this study were grown according to the manufacturer’s instructions. CAMA-1 cells (ATCC® HTB-21™) express a low level of HLA-A2 that results in very low surface levels, thus this cell line was transduced

(19) ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancereLifeSeptember 29, 2023Farmaki E, Nath A, Emond R, Karimi KL, Grolmusz VK, Cosgrove PA, Bild AH.strategy for future clinical trials. Materials and methods Cell culture and reagents CAMA-1 (ATCC HTB-21) and MCF7 (ATCC HTB-22) human BC cell lines were maintained in Dulbecco's Modified Eagle Medium (DMEM)

(20) Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of CancerMolecular cancer therapeuticsSeptember 5, 2023Toader D, Fessler SP, Collins SD, Conlon PR, Bollu R, Catcott KC, Chin CN, Dirksen A, Du B, Duvall JR, et al.cultured in DMEM:F12K with 10% FBS and 1% penicillin/streptomycin. CAMA-1 cells (RRID:CVCL_1115; ATCC HTB-21) were cultured in EMEM with 10% FBS and 1% penicillin/streptomycin. HEK293 cells (RRID:CVCL_0045; ATCC

Be the First to Write a Review!

Description

Specifications/Features

ATCC

Citations (42)

Reviews

CAMA-1 from ATCC

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map